Design, development and optimization of tedizolid phosphate carbopol based emulgel for skin drug delivery

Authors

  • Madhavi Nimmathota Department of Pharmaceutics, CMR College of Pharmacy, Medchal. Kandlakoya, Hyderabad-501401, India
  • Sravani Chokkarapu Department of Pharmaceutics, CMR College of Pharmacy, Medchal. Kandlakoya, Hyderabad-501401, India
  • Akshitha Tirumali Department of Pharmaceutics, CMR College of Pharmacy, Medchal. Kandlakoya, Hyderabad-501401, India
  • Umamaheshwara Rao Vattikuti Department of Pharmacognosy, CMR College of Pharmacy, Medchal. Kandlakoya, Hyderabad-501401

DOI:

https://doi.org/10.69857/joapr.v14i4.2031

Keywords:

Emulgel, In vitro, Ex vivo, Antimicrobial, Transdermal

Abstract

Background: Tedizolid phosphate (TZP) is effective against Gram-positive pathogens. It is used most widely in skin infections. Currently, there is no development of emulgels with this novel antibiotic molecule. Hence, the current research focused on developing emulgels for effective topical antimicrobial action to overcome disadvantages associated with oral drug delivery. Methodology: The drug spectroscopic method was developed using a UV-visible spectrophotometer. The o/w emulsions were prepared and incorporated into a gel base to form an emulgel. The prepared emulgels were subjected to physicochemical, IR spectral, antimicrobial, and biophysical analysis. Results and Discussion: Physical examination revealed clear emulgel texture for all test formulations, with maximum spreadability and rheology for carbopol 934 compared to HPMCK 15 and sodium CMC bases. The optimized carbopol 934-based EF7 formulation showed 86% in vitro drug release and 73% ex vivo drug release in 12 hours, respectively. The FTIR studies clearly indicate no incompatibility among the drug and excipients. All physicochemical parameters confirmed controlled release, and FTIR studies confirmed no incompatibility. The optimized emulgel showed good bacterial growth inhibition, and pathological studies confirmed the absence of alteration of porcine ear skin structure. Conclusion: The results indicate that the optimized formulation is suitable for the treatment of acute skin infection.

Downloads

Download data is not yet available.

References

Yousefian F, Hesari R, Jensen T. Antimicrobial wound dressings: a concise review for clinicians. Antibiotics, 12, 1434 (2023) https://doi.org/10.3390/antibiotics12091434

Smith R, Russo J, Fiegel J, Brogden N. Antibiotic delivery strategies to treat skin infections when innate antimicrobial defense fails. Antibiotics, 9, 56 (2020) https://doi.org/10.3390/antibiotics9020056

Raina N, Rani R, Thakur VK, Gupta M. New insights in topical drug delivery for skin disorders: from a nanotechnological perspective. ACS Omega, 8, 19145–19167 (2023) https://doi.org/10.1021/acsomega.2c08016

Yeh YC, Huang TH, Yang SC, Chen CC, Fang JY. Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances. Front Chem, 8, 286 (2020) https://doi.org/10.3389/fchem.2020.00286

Zhao L, Chen J, Bai B. Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing. Front Pharmacol, 14, 1333986 (2024) https://doi.org/10.3389/fphar.2023.1333986

Cheng T, Tai Z, Shen M. Advance and challenges in the treatment of skin diseases with the transdermal drug delivery system. Pharmaceutics, 15, 2165 (2023) https://doi.org/10.3390/pharmaceutics15082165

Guy RH. Drug delivery to and through the skin. Drug Deliv Transl Res, 14, 2032–2040 (2024) https://doi.org/10.1007/s13346-024-01614-w

Haq Khan ZU, Khan TM, Khan A. Brief review: applications of nanocomposite in electrochemical sensor and drugs delivery. Front Chem, 11, 1152217 (2023) https://doi.org/10.3389/fchem.2023.1152217

Jain KK. An overview of drug delivery systems. Drug Deliv Syst, 2059, 1–54 (2020) https://doi.org/10.1007/978-1-4939-9798-5_1

Singh R, Singh S, Lillard JW Jr. Past, present, and future technologies for oral delivery of therapeutic proteins. J Pharm Sci, 97, 2497–2523 (2008) https://doi.org/10.1002/jps.21183

Light K, Karboune S. Emulsion, hydrogel and emulgel system and novel application in cannabinoid delivery: a review. Crit Rev Food Sci Nutr, 62, 8199–8229 (2022) https://doi.org/10.1080/10408398.2021.1926903

Hasan S, Bhandari S, Sharma A, Garg P. Emulgel: a review. Asian J Pharm Res, 11, 263–268 (2021) https://doi.org/10.52711/231-5691.2021.00047

Waghmare ND, Hiwe KA, Bakal RL, Hatwar PR, Khansole NG, Wagh US. Emulgel: a novel topical drug delivery system. Asian J Pharm Res Dev, 13, 82–91 (2025) https://doi.org/10.22270/ajprd.v13i2.1545

Navarro-Partida J, Castro-Castaneda CR, Santa Cruz-Pavlovich FJ, Aceves-Franco LA, Guy TO, Santos A. Lipid-based nanocarriers as topical drug delivery systems for intraocular diseases. Pharmaceutics, 13, 678 (2021) https://doi.org/10.3390/pharmaceutics13050678

Jain A, Bhise K. Biogenic zinc oxide nanoparticles from Saraca asoca: cytotoxicity, antioxidant, antimicrobial evaluation, and topical gel development. J Appl Pharm Res, 13(5), 147–164 (2025) https://doi.org/10.69857/joapr.v13i5.1300

Donthi MR, Munnangi SR, Krishna KV, Saha RN, Singhvi G, Dubey SK. Nanoemulgel: a novel nano carrier as a tool for topical drug delivery. Pharmaceutics, 15, 164 (2023) https://doi.org/10.3390/pharmaceutics15010164

Talat M, Zaman M, Khan R, Jamshaid M, Akhtar M, Mirza AZ. Emulgel: an effective drug delivery system. Drug Dev Ind Pharm, 8, 1193–1199 (2021) https://doi.org/10.1080/03639045.2021.1993889

Patel BM, Kuchekar AB, Pawar SR. Emulgel approach to formulation development: a review. Biosci Biotech Res Asia, 18, 459–465 (2021) https://doi.org/10.13005/bbra/2931

Milutinov J, Krstonosic V, Cirin D, Pavlovic N. Emulgels: promising carrier systems for food ingredients and drugs. Polymers, 15, 2302 (2023) https://doi.org/10.3390/polym15102302

Bujubarah MM, Elsewedy HS, Shehata TM, Soliman WE. Formulation by design of an innovative tea tree oil nanoemulgel incorporating mupirocin for enhanced wound healing activity. Appl Sci, 13, 13244 (2023) https://doi.org/10.3390/app132413244

Idyryshev B, Muratbayev A, Tashybayeva M, Spanova A, Amirkhanov S, Serikova A, et al. Development and characterization of emulsion gels with pine nut oil, inulin, and whey proteins for reduced-fat meat products. Foods, 14, 962 (2025) https://doi.org/10.3390/foods14060962

Parihar N, Saini M, Soni SL, Sharma V. Emulgel: a topical preparation. Asian J Pharm Res Dev, 8, 196–201 (2020) https://doi.org/10.22270/ajprd.v8i3.765

Sharaff CS, Renukuntla P, Peddapalli H, Kuchukuntla M, Bakshi V, Jadi RK. Formulation, development, and characterization of loratadine emulgel. J Appl Pharm Res, 12(2), 42–50 (2024) https://doi.org/10.18231/j.joapr.2024.12.2.42.50

Fakir JS, Ahire CM, Surana KR, Kalam A, Ahamad AA, Davanage MD, et al. Formulation and evaluation of antibacterial and anti-inflammatory emulgel containing Eugenia caryophyllus buds extract. Biotech Res Asia, 21, 1183–1196 (2024) https://doi.org/10.13005/bbra/3296

Likitha B, Sheeba FR, Yeshavantha Kumar, Shivanand KM, Keerthy HS. Emulgel: a novel topical drug delivery. Res J Pharm Dosage Forms Technol, 15, 123–130 (2023) https://doi.org/10.52711/0975-4377.2023.00021

Khan BA, Ahmad S, Khan MK, Hosny KM, Bukhary DM, Iqbal H, et al. Fabrication and characterizations of pharmaceutical emulgel co-loaded with naproxen-eugenol for improved analgesic and anti-inflammatory effects. Gels, 8, 608 (2022) https://doi.org/10.3390/gels8100608

Sahu S, Choudhury PK, Pasa G, Murthy PN, Sahu P, Verma R. Modulation of mesalamine release from enteric-coated matrix tablets using natural polysaccharides for localized colonic delivery. J Appl Pharm Res, 12(2), 93–108 (2024) https://doi.org/10.18231/j.joapr.2024.12.2.93.108

Cortell-Fuster C, Martinez-Gomez M, Cercos-Lleti A. Optimization, formulation, and stability of topical rapamycin used for rare tuberous sclerosis disease: from ointment to liposomes. J Pharm Innov, 18, 2287–2293 (2023) https://doi.org/10.1007/s12247-023-09792-9

Keck CM, Abdelkader A, Pelikh O, Wiemann S, Kaushik V, Specht D, et al. Assessing the dermal penetration efficacy of chemical compounds with the ex vivo porcine ear model. Pharmaceutics, 14, 678 (2022) https://doi.org/10.3390/pharmaceutics14030678

Brighenti MS, Montanheri LRDS, Duque MD. In vitro drug release and ex vivo dermal drug permeation studies of selected commercial benzoyl peroxide topical formulations: correlation between human and porcine skin models. Mol Pharm, 22, 1365–1372 (2025) https://doi.org/10.1021/acs.molpharmaceut.4c01058

Shiehzadeh F, Mohebi D, Chavoshian O. Formulation, characterization, and optimization of a topical gel containing tranexamic acid to prevent superficial bleeding: in vivo and in vitro evaluations. Turk J Pharm Sci, 20, 261–269 (2023) https://doi.org/10.4274/tjps.galenos.2022.60687

Okafo SE, Anie CO, Alalor CA, Nwankwo LU. Evaluation of physicochemical and antimicrobial properties of creams formulated using Pterocarpus santalinoides seeds methanol extract. J Appl Pharm Sci, 13, 126–135 (2023) https://doi.org/10.7324/JAPS.2023.19934

Puyathorn N, Senarat S, Lertsuphotvanit N, Phaechamud T. Physicochemical and bioactivity characteristics of doxycycline hyclate-loaded solvent removal-induced ibuprofen-based in situ forming gel. Gels, 9, 128 (2023) https://doi.org/10.3390/gels9020128

Shreya L, Suma US, Zohmingliani R. Recent advances in oral in situ gel drug delivery system: a polymeric approach. Drug Dev Ind Pharm, 51, 1639–1649 (2025) https://doi.org/10.1080/03639045.2025.2559033

Sadozai SK, Khan SA, Baseer A, Ullah R, Zeb A, Schneider M. In vitro, ex vivo, and in vivo evaluation of nanoparticle-based topical formulation against Candida albicans infection. Front Pharmacol, 13, 909851 (2022) https://doi.org/10.3389/fphar.2022.909851

Yasmin Begum M, Alqahtani A, Ghazwani MM, Hani RU, Akhtar A, Rahamathulla M. Preparation of Carbopol 934 based ketorolac tromethamine buccal mucoadhesive film: in vitro, ex vivo, and in vivo assessments. Int J Polym Sci, 2021, 1–11 (2021) https://doi.org/10.1155/2021/4786488

Yadav KK, Laware RB, Kanawade SN. Formulation and evaluation of ethosomal gel containing Nyctanthes arbor-tristis leaf extract using design of experiments for enhanced topical delivery. J Appl Pharm Res, 13(5), 203–215 (2025) https://doi.org/10.69857/joapr.v13i5.1533

Campana R, Tiboni M, Maggi F, Cappellacci L, Cianfaglione K, Morshedloo MR, et al. Comparative analysis of the antimicrobial activity of essential oils and their formulated microemulsions against foodborne pathogens and spoilage bacteria. Antibiotics, 11, 447 (2022) https://doi.org/10.3390/antibiotics11040447

Priyadarshini P, Karwa P, Syed A, Asha AN. Formulation and evaluation of nanoemulgels for the topical drug delivery of posaconazole. J Drug Deliv Ther, 13, 33–43 (2023) https://doi.org/10.22270/jddt.v13i1.5896

Ozon EA, Anastasescu M, Musuc AM. Formulation and characterization of carbopol-based porphyrin gels for targeted dermato-oncological therapy: physicochemical and pharmaco-technical insights. Int J Mol Sci, 26, 3641 (2025) https://doi.org/10.3390/ijms26083641

Published

2026-07-31

How to Cite

Madhavi Nimmathota, Chokkarapu, S. ., Tirumali, A., & Vattikuti, U. R. (2026). Design, development and optimization of tedizolid phosphate carbopol based emulgel for skin drug delivery. Journal of Applied Pharmaceutical Research, 14(4), 187-198. https://doi.org/10.69857/joapr.v14i4.2031

Issue

Section

Articles